{"id":881459,"date":"2025-09-03T09:52:39","date_gmt":"2025-09-03T13:52:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/"},"modified":"2025-09-03T09:52:39","modified_gmt":"2025-09-03T13:52:39","slug":"vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/","title":{"rendered":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., Sept.  03, 2025  (GLOBE NEWSWIRE) &#8212; SOUTH SAN FRANCISCO, Calif., September 2, 2025 \u2014 Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place September 8-10, 2025.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Details<\/strong>:<br \/>Date and Time:\u00a0Monday, September 8 at\u00a012:00 PM ET<br \/>Webcast:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Yo2YBpidzWGTmmeE-Mqc5cz2Avd954VCSQtSxglvNA9NgZszrdZQEGImoJQC21acQTwNjTmuD8_fRIJk8Ru7xK65V95gJ3dqw92Dfk8FljhM167XmfeXFb6u73ey8QP7CsHYGgM5iudqQVXOKDplA==\" rel=\"nofollow\" target=\"_blank\"><u>Click Here<\/u><\/a><\/p>\n<p align=\"justify\">A live webcast will be available on the Company\u2019s investor relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZJuDN4ecLIEkba25yDZkesj2AUNw_nCqng2pGc7FP2ds0tevqplFg94bReSSNU4RfK42M2hkPr05irBZW__nZzqmNNG2IedmTtxV9OyxbsjejZ0I-FLqeKkHdIJfCMxD\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.vaxart.com<\/a>, and a replay of the presentation will be available for 30 days following the conclusion of the event.<\/p>\n<p align=\"justify\">Investors interested in meeting with management during the conference may reach out to their H.C. Wainwright representative.<\/p>\n<p align=\"justify\">\n        <strong>About Vaxart<\/strong>\n      <\/p>\n<p align=\"justify\">Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart\u2019s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart\u2019s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Vaxart\u00a0Media and Investor Relations:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Matt Steinberg<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">FINN Partners<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\n            <a href=\"mailto:IR@vaxart.com\" rel=\"nofollow\" target=\"_blank\">IR@vaxart.com<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">(646) 871-8481<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDg1MGEyYWItNTJlMi00OWE2LWFhN2MtMTNhNjAzYWM3MzMxLTEwMzA2ODItMjAyNS0wOS0wMy1lbg==\/tiny\/Vaxart-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) &#8212; SOUTH SAN FRANCISCO, Calif., September 2, 2025 \u2014 Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place September 8-10, 2025. Presentation Details:Date and Time:\u00a0Monday, September 8 at\u00a012:00 PM ETWebcast:\u00a0Click Here A live webcast will be available on the Company\u2019s investor relations website at https:\/\/investors.vaxart.com, and a replay of the presentation will be available for 30 days following the conclusion of the event. Investors interested in meeting with management during the conference may reach out to their H.C. Wainwright representative. About Vaxart Vaxart &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-881459","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) &#8212; SOUTH SAN FRANCISCO, Calif., September 2, 2025 \u2014 Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place September 8-10, 2025. Presentation Details:Date and Time:\u00a0Monday, September 8 at\u00a012:00 PM ETWebcast:\u00a0Click Here A live webcast will be available on the Company\u2019s investor relations website at https:\/\/investors.vaxart.com, and a replay of the presentation will be available for 30 days following the conclusion of the event. Investors interested in meeting with management during the conference may reach out to their H.C. Wainwright representative. About Vaxart Vaxart &hellip; Continue reading &quot;Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-03T13:52:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025\",\"datePublished\":\"2025-09-03T13:52:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/\",\"name\":\"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\",\"datePublished\":\"2025-09-03T13:52:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/","og_locale":"en_US","og_type":"article","og_title":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) &#8212; SOUTH SAN FRANCISCO, Calif., September 2, 2025 \u2014 Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place September 8-10, 2025. Presentation Details:Date and Time:\u00a0Monday, September 8 at\u00a012:00 PM ETWebcast:\u00a0Click Here A live webcast will be available on the Company\u2019s investor relations website at https:\/\/investors.vaxart.com, and a replay of the presentation will be available for 30 days following the conclusion of the event. Investors interested in meeting with management during the conference may reach out to their H.C. Wainwright representative. About Vaxart Vaxart &hellip; Continue reading \"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-03T13:52:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025","datePublished":"2025-09-03T13:52:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/","name":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=","datePublished":"2025-09-03T13:52:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMTkxMiM3MTI1NTA5IzIwMTkxMDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-present-at-the-h-c-wainwright-global-investment-conference-on-september-8-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=881459"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/881459\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=881459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=881459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=881459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}